MA HD 3233
in committeeAn Act relative to assessing the feasibility of in-state drug manufacturing
Massachusetts · 2025-2026 Regular Session (194th General Court) · lower
Quick answers
Did MA HD 3233 pass?
Not yet. MA HD 3233 is in committee as of 2025-02-27 and has not come to a final vote. Latest recorded action (2025-02-27): Senate concurred
What is MA HD 3233 about?
By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 763) of Marjorie C. Decker for an investigation by a special commission (including members of the General Court) relative to the feasibility of state-sponsored prescription drug manufacturing or distribution in the Commonwealth. Elder Affairs.
Who sponsors MA HD 3233?
Marjorie C. Decker is the primary sponsor of MA HD 3233.
Description
By Representative Decker of Cambridge, a petition (accompanied by bill, House, No. 763) of Marjorie C. Decker for an investigation by a special commission (including members of the General Court) relative to the feasibility of state-sponsored prescription drug manufacturing or distribution in the Commonwealth. Elder Affairs.
- Introduced
- —
- Latest action
- 2025-02-27 — Senate concurred
- Bill type
- proposed bill
- Last updated
- —
Sponsors
- Marjorie C. Deckerprimary
Committees
Not provided by source.
Action timeline
2025-02-27
Referred to the committee on Elder Affairs
referral-committee
2025-02-27
Senate concurred
Versions
- Bill TextCompare
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:56.590024Z
Inspect retained evidence for changes recorded after evidence tracking began:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MA&identifier=HD 3233. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.